drugset
Drugs / [68Ga]Ga-NODAGA-E[c(RGDyK)]2
last change Jan 2026 re-read 3 minutes ago

[68Ga]Ga-NODAGA-E[c(RGDyK)]2

Diagnostic / imaging agent

Investigated by
Rigshospitalet, Denmark

Trials 1

today NCT03393689 · Ph 2
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03393689 Jan 2018 → Jan 2021 acoustic neuroma Rigshospitalet, Denmark Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as [68Ga]Ga-NODAGA-E[c(RGDyK)]2 “our PET tracer [68Ga]Ga-NODAGA-E[c(RGDyK)]2 could be used to predict initial sVS growth rate” PMID 41530428 ↗ Jan 2026
Modality Diagnostic / imaging agent “our PET tracer [68Ga]Ga-NODAGA-E[c(RGDyK)]2 could be used to predict initial sVS growth rate” PMID 41530428 ↗ Jan 2026
Route Intravenous “All patients were injected intravenously with approximately 200 MBq of the tracer” PMID 41530428 ↗ Jan 2026